日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical Trials

对接受早期全疗程治疗的多发性骨髓瘤患者进行长期随访:3项临床试验的二次分析

Al Hadidi, Samer; Ababneh, Obada Ehab; Schinke, Carolina D; Thanendrarajan, Sharmilan; Siegel, Eric R; Bailey, Clyde; Smith, Robert; Panozzo, Susan B; Zangari, Maurizio; Tricot, Guido; Shaughnessy, John D Jr; Zhan, Fenghuang; Sawyer, Jeffrey; Barlogie, Bart; van Rhee, Frits

Altered mesenchymal and endothelial subsets in interstitial bone marrow and focal lesions in myeloma patients and SCID-hu mice

多发性骨髓瘤患者和SCID-hu小鼠骨髓间质和局灶性病变中间质和内皮细胞亚群的改变

Ling, Wen; Zangari, Maurizio; Van Rhee, Frits; Barlogie, Bart; Yaccoby, Shmuel

Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imaging

多发性骨髓瘤中局灶性病变位置和持续时间的预后影响:来自连续PET/DWI成像的启示

Schinke, Carolina; Rasche, Leo; Ashby, Cody; van Hemert, Rudy; Thanendrarajan, Sharmilan; Al Hadidi, Samer; Zangari, Maurizio; Bailey, Clyde; Alapat, Daisy V; Shaughnessy, John D Jr; Zhan, Fenghuang; Barlogie, Bart; van Rhee, Frits; Weinhold, Niels

Induction of HMOX1 by mesenchymal stem cell cytotherapy inhibits osteoclastogenesis and myeloma-induced bone disease

间充质干细胞细胞疗法诱导HMOX1表达可抑制破骨细胞生成和骨髓瘤引起的骨病

Li, Xin; Ling, Wen; Barlogie, Bart; Yaccoby, Shmuel

The Placenta Regulates Intrauterine Fetal Growth via Exosomal PPARγ (Adv. Sci. 15/2025)

胎盘通过外泌体PPARγ调节宫内胎儿生长(Adv. Sci. 15/2025)

Li, Xin; Ling, Wen; Pennisi, Angela; Wang, Yuping; Khan, Sharmin; Heidaran, Mohammad; Pal, Ajai; Zhang, Xiaokui; He, Shuyang; Zeitlin, Andy; Abbot, Stewart; Faleck, Herbert; Hariri, Robert; Shaughnessy, John D Jr; van Rhee, Frits; Nair, Bijay; Barlogie, Bart; Epstein, Joshua; Yaccoby, Shmuel; Luo, Xiaofang; Huang, Biao; Xu, Ping; Wang, Hao; Zhang, Baozhen; Lin, Li; Liao, Jiujiang; Hu, Mingyu; Liu, Xiyao; Huang, Jiayu; Fu, Yong; Kilby, Mark D; Kellems, Rodney E; Fan, Xiujun; Xia, Yang; Baker, Philip N; Qi, Hongbo; Tong, Chao

Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma

针对新诊断的多发性骨髓瘤患者,开发和验证个体化加权骨髓瘤预后评分系统(MPSS)

Mao, Xuehan; Yan, Wenqiang; Mery, David; Liu, Jiahui; Fan, Huishou; Xu, Jingyu; Xu, Yan; Sui, Weiwei; Deng, Shuhui; Zou, Dehui; Du, Chenxing; Yi, Shuhua; van Rhee, Frits; Barlogie, Bart; Shaughnessy, John D Jr; Anderson, Kenneth C; Zhan, Fenghuang; Qiu, Lugui; An, Gang

A gene signature can predict risk of MGUS progressing to multiple myeloma

基因特征可以预测MGUS进展为多发性骨髓瘤的风险。

Sun, Fumou; Cheng, Yan; Ying, Jun; Mery, David; Al Hadidi, Samer; Wanchai, Visanu; Siegel, Eric R; Xu, Hongwei; Gai, Dongzheng; Ashby, Timothy Cody; Bailey, Clyde; Chen, Jin-Ran; Schinke, Carolina; Thanendrarajan, Sharmilan; Zangari, Maurizio; Janz, Siegfried; Barlogie, Bart; Van Rhee, Frits; Tricot, Guido; Shaughnessy, John D Jr; Zhan, Fenghuang

CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation

CST6 通过阻断破骨细胞分化来抑制多发性骨髓瘤中的溶骨性骨病

Dongzheng Gai, Jin-Ran Chen, James P Stewart, Intawat Nookaew, Hasem Habelhah, Cody Ashby, Fumou Sun, Yan Cheng, Can Li, Hongwei Xu, Bailu Peng, Tarun K Garg, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Fangping Chen, Bart Barlogie, Frits van Rhee, Guido Tricot, John D Shaughnessy

The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma

冒烟型骨髓瘤的分子组成突出了导致多发性骨髓瘤的进化途径

Eileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, Cody Ashby, Yan Wang, Michael A Bauer, Sarah K Johnson, Christopher P Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Facon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H Rustad, Francesco Maura, Ola Landgren, Fenghuang Zhan,

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)

SWOG S0777 随机 III 期试验的长期随访:硼替佐米、来那度胺和地塞米松与来那度胺和地塞米松治疗既往未接受治疗的多发性骨髓瘤患者(Pts),且不打算立即进行自体干细胞移植(ASCT)。

Durie, Brian G M; Hoering, Antje; Sexton, Rachael; Abidi, Muneer H; Epstein, Joshua; Rajkumar, S Vincent; Dispenzieri, Angela; Kahanic, Stephen P; Thakuri, Mohan C; Reu, Frederic J; Reynolds, Christopher M; Orlowski, Robert Z; Barlogie, Bart